SERUM IgA ANTIBODIES TO EPSTEIN-BARR VIRUS CAPSID ANTIGEN PRECEDING SYMPTOMS OF NASOPHARYNGEAL CARCINOMA
- 25 February 1978
- journal article
- other
- Published by Elsevier BV in The Lancet
- Vol. 311 (8061), 436
- https://doi.org/10.1016/s0140-6736(78)91220-5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Nasopharyngeal carcinoma: Significance of changes in epstein‐barr virus‐related antibody patterns following therapyInternational Journal of Cancer, 1977
- IgA antibodies to Epstein-Barr viral capsid antigens in saliva of nasopharyngeal carcinoma patientsBritish Journal of Cancer, 1977
- Neutralizing EBV‐specific IgA in throat washings of nasopharyngeal carcinoma (NPC) patientsInternational Journal of Cancer, 1977
- Epstein-Barr-virus-specific IgA and IgG serum antibodies in nasopharyngeal carcinomaBritish Journal of Cancer, 1976
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976
- Direct Evidence for the Presence of Epstein-Barr Virus DNA and Nuclear Antigen in Malignant Epithelial Cells from Patients with Poorly Differentiated Carcinoma of the NasopharynxProceedings of the National Academy of Sciences of the United States of America, 1974
- Demonstration of epstein‐barr virus‐associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsiesInternational Journal of Cancer, 1974